TB-500Healing & Recovery
Thymosin Beta-4 fragment studied for recovery and flexibility.
Overview
"TB-500" is a research peptide sold as related to Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid actin-sequestering peptide involved in cell migration, angiogenesis and wound repair. Analytical work shows commercial "TB-500" typically contains a synthetic fragment of Tβ4 (the N-terminal acetylated 17-23 region), not the full molecule — so it should not be treated as identical to pharmaceutical Tβ4. It is sold research-use-only, has not been evaluated by the FDA, and is prohibited in sport.
How it works
Tβ4 is the major monomeric (G-)actin-sequestering peptide in cells, forming a 1:1 complex with actin that regulates cytoskeletal dynamics, cell migration, blood-vessel formation and tissue repair. Preclinical work attributes some reparative and pro-survival effects to a complex with PINCH and integrin-linked kinase (ILK) that activates the Akt survival pathway in cardiac cells. These mechanisms are characterized for Tβ4; the truncated TB-500 fragment is presumed to share actin-binding activity but is far less studied as an intact agent.
Evidence
There are no published human clinical trials of the research chemical "TB-500" itself. The regeneration evidence base for Tβ4 is overwhelmingly animal and in-vitro (e.g., murine cardiac-repair and myocardial-infarction models). The only controlled human trials studied a different, pharmaceutical-grade Tβ4 product — RGN-259, a topical ophthalmic solution — for niche eye conditions; a phase 3 RCT reported improved corneal healing in neurotrophic keratopathy. Those results pertain to a regulated eye drop and do not demonstrate efficacy or safety of injected "TB-500" for muscle, tendon or systemic healing.
Anecdotal reports community-reported
What people describe in forums, blogs and uncontrolled clinic write-ups — experiential and unverified, not clinical evidence and not medical advice.
- Tendon, ligament & joint recoverythe most commonly reported use
Recovering from nagging tendon and joint injuries is the dominant reason users report reaching for TB-500, usually alongside BPC-157. A widely-read r/bpc_157 account describes a 3+ year suspected rotator-cuff problem improving markedly after months of self-managed use. Enthusiastic but uncontrolled and unverifiable.
- Reduced pain and better range of motionfrequently reported
The benefit is often framed as day-to-day relief rather than a cure — the same rotator-cuff write-up describes pain with overhead movement and sleeping on the shoulder easing, and range of motion returning over weeks. Self-reported and unverified.
- Used body-wide for several areas at oncecommonly reported
Because TB-500 is described as acting systemically (versus BPC-157's more local action), people often run it to target several problem areas at the same time — one r/bpc_157 log lists tennis elbow, frozen shoulder, bicep tendonitis and shoulder arthritis being addressed together. Whole-body intent, but the effect on any single site can't be isolated.
- Wound and skin-healing anecdotesoccasionally reported
Beyond joints, some users report faster wound and skin healing — a commenter on one r/bpc_157 thread describes second-degree forearm burns healing unusually quickly while running a BPC-157/TB-500 stack. A striking single anecdote, not evidence.
- Typically stacked with BPC-157 for recoveryvery frequently reported
TB-500 is rarely used alone; logs pair it with BPC-157 (and often GHK-Cu, ipamorelin or CJC-1295) as a recovery stack, with the systemic TB-500 seen as complementing BPC-157's more localized effect. Users credit the combination, so TB-500's individual contribution can't be separated.
Safety
Human safety of "TB-500" is essentially unstudied; it is sold as a research compound with no established purity standards or human dosing data, and the only human safety experience is with the unrelated topical Tβ4 product. TB-500/Tβ4 is on the WADA Prohibited List (prohibited at all times, peptide-hormones / growth-factors class) and is detectable in anti-doping testing, so its use is banned in sport. Research use only; no therapeutic or dosing guidance.
Reported side effects
Reported in published literature and user reports. Not a complete list, and not medical advice.
- Injection-site reactions
- Fatigue or headache (anecdotal)
- Limited human safety data
If severe or unexpected symptoms occur, contact a qualified medical professional. PEPTIDES·INDEX does not provide medical advice.
Cautions discuss with a clinician
- No human contraindication data exist for TB-500; the cautions below are theoretical and grounded in preclinical biology, not human findings.
- As a pro-angiogenic, pro-migration agent, TB-500 carries a theoretical caution with active malignancy (promoting blood-vessel formation and cell migration could in principle support tumor spread); this concern is animal-derived and has not been demonstrated in humans.
- Prohibited in sport at all times; not for human consumption. No safety data exist for use during pregnancy, breastfeeding, or any medical condition.
- No documented human drug interactionsInteraction profile uncharacterized in humans (research use only)
Timeline commonly reported
- Weeks 1–4
No controlled human data exists for TB-500. Anecdotal recovery protocols describe effects over weeks; animal Tβ4 healing studies run on similar timescales but do not transfer to humans.
- Weeks 4–8
Self-reported plateau in typical anecdotal use; the human time-course is uncharacterized, and TB-500 is prohibited in sport.
FAQ
Is TB-500 FDA-approved?
No. TB-500 has not been evaluated by the FDA and is sold research-use-only. The only controlled human trials involved a different, pharmaceutical-grade thymosin beta-4 eye drop (RGN-259), not injected TB-500.
Is TB-500 the same as thymosin beta-4?
Not exactly. Analytical work shows commercial TB-500 is typically a synthetic fragment of thymosin beta-4 (the N-terminal acetylated 17-23 region), not the full 43-amino-acid molecule, so it should not be treated as identical to pharmaceutical Tbeta4.
Is TB-500 banned in sport?
Yes. TB-500/thymosin beta-4 is on the WADA Prohibited List (prohibited at all times) and is detectable in anti-doping testing.
How does TB-500 work?
The parent peptide Tbeta4 is the major monomeric (G-)actin-sequestering peptide in cells, forming a 1:1 complex with actin that regulates the cytoskeleton, cell migration, blood-vessel formation and repair; some reparative effects are attributed to a PINCH/ILK-Akt survival pathway. These mechanisms are characterized for full Tbeta4 in preclinical models, and the truncated TB-500 fragment is far less studied as an intact agent.
What route is TB-500 used by?
In anecdotal protocols it is injected subcutaneously or intramuscularly; there is no oral form with evidence behind it. Crucially there are no human trials of injected TB-500, so dose, route and any benefit in people are unestablished.
How does TB-500 compare with BPC-157?
They are frequently paired in anecdotal recovery protocols and are both preclinical repair peptides with no human efficacy trials. A key difference: TB-500/Tbeta4 is explicitly on the WADA Prohibited List and is detectable in testing, so it is a clear anti-doping violation. Both should be treated as research-use-only.
Related guides
Sources
Starting references for the library summary. These are not dosing instructions or medical advice.
For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.